Age <50 | Age 50-65 | Age >65 | P* | |
---|---|---|---|---|
Mean (SD) | Mean (SD) | Mean (SD) | ||
Global health status (2) | 83.4 (19.8) | 84.1 (18.3) | 80.5 (17.5) | 0.057 |
Physical functioning (5) | 89.7 (16.5) | 86.7 (17.8) | 78.9 (21.3) | <0.001 |
Role functioning (2) | 85.9 (27.4) | 86.7 (24.4) | 90.3 (18.0) | 0.839 |
Body image (4) | 69.7 (29.6) | 82.8 (22.4) | 90.4 (18.2) | <0.001 |
Sexual functioning (2) | 38.8 (24.5) | 27.6 (26.2) | 16.2 (22.6) | <0.001 |
Sexual enjoyment (1) | 56.7 (33.0) | 45.6 (34.6) | 31.5 (33.0) | <0.0002 |
Future perspective (1) | 46.7 (34.9) | 55.2 (32.0) | 70.6 (28.3) | <0.001 |
Side effects from chemotherapy (8)# | 17.3 (16.8) | 16.0 (16.3) | 13.3 (13.5) | 0.107 |
Breast symptoms (4)# | 15.7 (18.5) | 15.7 (19.3) | 10.7 (11.8) | 0.210 |
Arm symptoms (3)# | 17.0 (26.2) | 13.1 (21.4) | 8.4 (13.9) | 0.135 |
Distress from loss of hair (3)# | 9.8 (25.0) | 17.2 (31.7) | 19.4 (31.1) | 0.092 |
QLQ-BR23 total (23) | 75.1 (14.3) | 78.1 (14.5) | 82.3 (10.8) | <0.001 |